Reported daily dosages of AOD9604 in research typically range from 200 to 500 mcg, with some studies exploring up to 1000 mcg daily. The table below outlines common target dosages.
| Experience Level | Daily Dosage | Typical Cycle Length (Weeks) |
|---|---|---|
| Beginner | 200–300 mcg | 4–8 weeks |
| Intermediate | 300–500 mcg | 8–12 weeks |
| Advanced | Up to 1000 mcg (1 mg) | Up to 12 weeks |
Note: Doses over 1000 mcg may not correlate with better results.
⏲️ Administration and Cycle Details
The peptide is typically administered once daily via subcutaneous injection, often in the morning on an empty stomach. Many protocols are cyclical, often recommending an 8-12 week "on" period followed by a "washout" period (e.g., 4 weeks) to maintain efficacy.
⚠️ Crucial Safety Considerations
No FDA Approval: AOD9604 is not approved by the U.S. FDA for therapeutic or clinical use.
Limited Safety Data: Long-term safety data beyond three months of use is not available.
Potential for Mild Side Effects: These can include injection site reactions, headaches, and fatigue.
https://www.hormonerawsource.com/peptides/superior-quality-aod9604-peptides-powder-for.html
